Drug intelligence / Profile preview

z-ligustilide

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal, Intravenous
01

Overview

Z-ligustilide is a natural phthalide compound, specifically an enol ester and benzoquinone derivative, found in various traditional Chinese medicinal plants, most notably Angelica sinensis (Danggui) and Ligusticum chuanxiong. It exhibits a range of pharmacological activities including neuroprotection, antioxidant, anti-inflammatory, and anticancer properties. Mechanistically, it is neuroprotective by activating the Nrf2-TrxR signaling axis, which promotes endogenous antioxidant capacity and drives microglial polarization toward the M2 (anti-inflammatory) phenotype, providing benefit in models of Parkinson's disease. In cancer cells, it induces apoptosis via ER stress signaling, c-Myc activation, and modulation of NRF2-related pathways. Preclinical studies indicate additional effects in models of depression, osteoarthritis, and inflammation, but Z-ligustilide is not an approved pharmaceutical and is primarily used in research or as a constituent of traditional herbal formulations[1][3][4][6][7].

Other names
cis-ligustilide(Z)-3-butylidene-4,5-dihydroisobenzofuran-1(3H)-oneLigustilide AZ-Ligustilide-RMLigustilideZ-(In Acetonitrile)(P)(Z)-Ligustilide (Chloroform Solution)Z-Ligustilide (50 mg) (COLD SHIPMENT)LIGUSTILIDEZ-[~10mg/ML IN ACETONITRILE(3Z)-3-butylidene-4,5-dihydro-2-benzofuran-1-one
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)TXNRD2 (Thioredoxin reductase 2)MYC (MYC proto-oncogene protein)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on z-ligustilide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on z-ligustilide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call